Financhill
Back

Blueprint Medicines Stock Price Chart

  • The current trend is relatively stagnant and BPMC is experiencing slight selling pressure.

Blueprint Medicines Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 86.1 Buy
20-day SMA: 84.11 Buy
50-day SMA: 88.24 Buy
200-day SMA: 94.67 Sell
8-day EMA: 86.39 Buy
20-day EMA: 85.79 Buy
50-day EMA: 88.74 Sell
200-day EMA: 92.18 Sell

Blueprint Medicines Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 55.57 Buy
Chaikin Money Flow: -41477 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (81.56 - 89.08) Buy
Bollinger Bands (100): (84.71 - 103.35) Sell

Blueprint Medicines Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Blueprint Medicines Stock

Is Blueprint Medicines Stock a Buy?

BPMC Technical Analysis vs Fundamental Analysis

Sell
43
Blueprint Medicines (BPMC) is a Sell

Is Blueprint Medicines a Buy or a Sell?

Blueprint Medicines Stock Info

Market Cap:
5.7B
Price in USD:
88.48
Share Volume:
573.5K

Blueprint Medicines 52-Week Range

52-Week High:
121.90
52-Week Low:
73.04
Sell
43
Blueprint Medicines (BPMC) is a Sell

Blueprint Medicines Share Price Forecast

Is Blueprint Medicines Stock a Buy?

  • Blueprint Medicines share price is 88.48 while BPMC 8-day exponential moving average is 86.39, which is a Buy signal.
  • The stock price of BPMC is 88.48 while Blueprint Medicines 20-day EMA is 85.79, which makes it a Buy.
  • Blueprint Medicines 50-day exponential moving average is 88.74 while BPMC share price is 88.48, making it a Sell technically.
  • BPMC stock price is 88.48 and Blueprint Medicines 200-day simple moving average is 92.18, creating a Sell signal.

Fundamental Analysis of Blueprint Medicines

Is Blueprint Medicines a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.63 per share, an increase next quarter of $0.06 per share, a decrease this year of $0.32 per share, and an increase next year of $2.76 per share.

Technical Analysis of Blueprint Medicines

Should I short Blueprint Medicines stock?

* Blueprint Medicines stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.